Human Drugs

× UPDATE! Updated as of 16 October 2024.
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View DR-XY49032 0.9% Sodium Chloride None 9 mg/mL (0.9% w/v) Solution for Injection (IV Infusion) Electrolyte Replenisher Shijiazhuang No. 4 Pharmaceutical Co., Ltd. China Initial 02 April 2024 02 April 2029
View DR-XY49033 0.9% Sodium Chloride None 9 mg/mL (0.9% w/v) Solution for Injection (IV Infusion) Electrolyte Replenisher Shijiazhuang No. 4 Pharmaceutical Co., Ltd. China Initial 02 April 2024 02 April 2029
View DRP-15068 Hydroxychloroquine Sulfate None 200mg Film-Coated Tablet Antimalarial (Aminoquinolines) Bafna Pharmaceuticals Limited India Initial 04 April 2024 04 April 2029
View DR-XY49037 Meropenem (as trihydrate) Aemero 500 500 mg Powder for Injection (I.V.) Antibacterial (Carbapenem) Reyoung Pharmaceutical Co., Ltd. China Initial 05 April 2024 05 April 2029
View DR-XY49036 Meropenem (as trihydrate) Aemero 1000 1 g Powder for Injection (I.V.) Antibacterial (Carbapenem) Reyoung Pharmaceutical Co., Ltd. China Initial 05 April 2024 05 April 2029
View DRP-15069 Levetiracetam Levsezur 100 mg/mL Oral Solution Antiepileptic Novagen Healthcare Private Limited India Initial 04 April 2024 04 April 2029
View DRP-15070 Levetiracetam None 100mg/mL Oral Solution Antiepileptic Novagen Healthcare Private Limited India Initial 04 April 2024 04 April 2029
View DR-XY49035 Rivaroxaban Verxaban 10 mg Film-Coated Tablet Antithrombotic Agent (Direct factor Xa inhibitor) Lloyd Laboratories, Inc. Philippines Initial 04 April 2024 04 April 2029
View DR-XY49034 Rivaroxaban Verxaban 15 mg Film-Coated Tablet Antithrombotic Agent (Direct factor Xa inhibitor) Lloyd Laboratories, Inc. Philippines Initial 04 April 2024 04 April 2029
View DRP-15071 Tobramycin (as sulfate) + Dexamethasone Tobramet 3 mg/1 mg per mL (0.3% /0.1% w/v) Ophthalmic Suspension Antibacterial and Corticosteroid Indiana Ophthalmics India Initial 04 April 2024 04 April 2029
View BR-1480 Spesolimab Spevigo 450 mg/7.5 mL (60 mg/mL) Concentrate for Solution for Infusion (IV) Interleukin inhibitors Boehringer Ingelheim Pharma GmbH & Co. KG Germany Monitored Release (MR) 05 April 2024 05 April 2029
View DRP-15022 Mupirocin Mupisur 20 mg/g (2% w/w) Cream Antibacterial Kwality Pharmaceuticals Limited India Initial [OTC] 04 April 2024 04 April 2029
View DRP-15067 Hydroxychoroquine Sulfate H-Klor 200mg Film-Coated Tablet Antimalarial (Aminoquinolines) Bafna Pharmaceuticals Limited India Initial 08 April 2024 08 April 2029
View DRP-10604-05 Levodropropizine Pecof Dry 30 mg/5 mL Syrup Cough Suppressant Lloyd Laboratories, Inc. Philippines CLIDP Conversion 29 May 2023 22 October 2026
View DRP-10604-04 Levodropropizine Levopres 30 mg/5 mL Syrup Cough Suppressant Lloyd Laboratories, Inc. Philippines CLIDP Conversion 26 April 2023 22 October 2026
View DRP-10604-02 Levodropropizine Rapifort 30 mg/5 mL Syrup Cough Suppressant Lloyd Laboratories, Inc Philippines CLIDP Conversion 09 February 2023 22 October 2026
View DRP-10604-03 Levodropropizine Peritus 30 mg/5 mL Syrup Cough Suppressant Lloyd Laboratories, Inc Philippines CLIDP Conversion 11 February 2023 22 October 2026
View DRP-15072 Ofloxacin Ofloxasaph-INF 2 mg/mL (200 mg/100 mL) Solution for Intravenous Infusion Antibacterial (Fluoroquinolone) Althea Pharma Pvt. Ltd. India Initial 12 April 2024 12 April 2029
View DRP-15074 Norepinephrine (as bitartrate) Norepin 16 1 mg/mL (16 mg/16 mL) Concentrate Solution. for IV Infusion Adrenergic Agent United Biotech Pvt. Ltd. India Initial 12 April 2024 12 April 2029
View DRP-15073 Methotrexate Trexglo 2.5 mg Tablet Antineoplastic Globela Pharma Private Limited India Initial 12 April 2024 12 April 2029